Pages that link to "Q33643154"

The following pages link to Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? (Q33643154):

Displaying 50 items.

• 50 years of hurdles and hope in anxiolytic drug discovery (Q28297569) (← links)
• Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity (Q28345790) (← links)
• Control by tachykinin NK2 receptors of CRF1 receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig (Q28573917) (← links)
• Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala (Q28574741) (← links)
• Emotional behaviour as the result of stochastic interactions. A process crucial for cognition. (Q30332207) (← links)
• Effects of intra-PAG infusion of ovine CRF on defensive behaviors in Swiss-Webster mice (Q30471568) (← links)
• The biology of fear- and anxiety-related behaviors (Q30473428) (← links)
• Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues (Q30485593) (← links)
• Neurobiology of generalized anxiety disorder (Q32064653) (← links)
• Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery. (Q34110269) (← links)
• The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. (Q34130568) (← links)
• The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review (Q34178687) (← links)
• The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety (Q34241289) (← links)
• Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? (Q34275762) (← links)
• Measuring normal and pathological anxiety-like behaviour in mice: a review. (Q34420641) (← links)
• Molecular pathways of anxiety revealed by knockout mice (Q34510367) (← links)
• Molecular targets in the treatment of anxiety (Q35001313) (← links)
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review (Q35071470) (← links)
• The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines (Q35071483) (← links)
• The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic (Q35071487) (← links)
• Neuroendocrine pharmacology of stress. (Q35071526) (← links)
• The neurobiology and control of anxious states (Q35202929) (← links)
• The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses. (Q37252310) (← links)
• Depression and antidepressants: molecular and cellular aspects. (Q37517285) (← links)
• Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression (Q37581584) (← links)
• Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor (Q40150944) (← links)
• Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS. (Q41864443) (← links)
• Characteristics of substance P transport across the blood-brain barrier (Q41945275) (← links)
• Neurokinin2‐R in medial septum regulate hippocampal and amygdalar ACh release induced by intraseptal application of neurokinins A and B (Q42477734) (← links)
• Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice (Q42673666) (← links)
• Changes in expression of the neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery. (Q44163276) (← links)
• CRF1-receptor antagonist CP-154526 reduces alerting-related cutaneous vasoconstriction in conscious rabbits (Q44328320) (← links)
• Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice (Q44413142) (← links)
• Plasma cortisol and neuropeptide Y in female victims of intimate partner violence (Q44482045) (← links)
• Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression (Q44709359) (← links)
• Conditioned fear is modulated by CRF mechanisms in the periaqueductal gray columns (Q46094457) (← links)
• Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system (Q46807755) (← links)
• Neuropeptides and anxiety (Q47743740) (← links)
• Pharmacological characterisation of cortical gamma-aminobutyric acid type A (GABAA) receptors in two Wistar rat lines selectively bred for high and low anxiety-related behaviour (Q48378821) (← links)
• Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column (Q48380691) (← links)
• Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites (Q48393555) (← links)
• GABAergic and NPY-Y(1) network in the medial amygdala: a neuroanatomical basis for their functional interaction (Q48765728) (← links)
• Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. (Q48821161) (← links)
• Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety (Q48862386) (← links)
• OrphaninFQ: role in behavioral fear responses and vulnerability to stress? (Q49137063) (← links)
• Stress-induced social avoidance: a new model of stress-induced anxiety? (Q51035897) (← links)
• Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups (Q51080724) (← links)
• Repeated treatment with cholecystokinin octapeptide improves maze performance in aged Fischer 344 rats (Q52018710) (← links)
• Atypical behavioural responses to CCK-B receptor ligands in Fawn-Hooded rats (Q52098737) (← links)
• Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians (Q60731237) (← links)